Auto logout in seconds.
Continue LogoutThe US health care industry has seen relatively few changes in how we deliver end-of-life care over the past several decades. However, the growing number of older adults, the lasting impact of Covid-19, and the shifting dynamics of Medicare enrollment are pressuring the industry to address longstanding challenges in this space. We have identified three emerging trends that, combined, have the potential to transform the end-of-life landscape. Stakeholders should be aware of, and prepare to react to, the shift of more end-of-life care to the home, the potential permanence of the Medicare Advantage (MA) carve-in for hospice, and the impact of more private equity (PE) ownership of hospice.
Industry stakeholders are responding to the desire for older adults to age in place, reduce overall cost of care, and improve patient control over care decisions. As a result, stakeholders are capitalizing on home-based care solutions for primary care all the way to end-of-life. A more comprehensive suite of home care services, rather than a point solution, can help avoid fragmentation in the care continuum and ‘slippages through the cracks’ that patients experience in post-acute and acute settings.
1. There’s a tight labor pool for these services, especially in rural areas. Creating a viable financial model for affordable in-home hospice can be challenging.
2. The burden on caregivers providing end of life care is significant. It’s important for them to have the ability to deal with potential complications. Hospice does not provide 24-hour care in the home except in short crisis situations, so symptom flare-ups like a spike in pain or difficulty breathing may be challenging to manage at home for caregivers.
3. Stakeholders must understand that end-of-life care in the home isn’t suitable for everyone — the home is not a one-size-fits-all destination for dying. Certain physically and emotionally burdensome end-of-life needs are difficult to manage with intermittent home hospice visits.
Historically, MA beneficiaries who wanted to enroll in hospice would have to switch to traditional Medicare. However, in 2021, CMS created the Medicare Advantage Value-Based Insurance Design Model (VBID), which includes a hospice benefit component. Participating MA organizations must offer advanced care planning, palliative care services, and transitional concurrent care for a period of one month for all seriously ill patients. The VBID Medicare carve-in is in its third year. Many expect that this will become permanent. In the case that it does, stakeholders — especially payers — will have to be prepared for how this will impact payment and interdisciplinary team structures since there will be a lot of debate around who should ‘own’ end-of-life payment decisions. More importantly, stakeholders will have to be prepared for how this will impact the quality of care for patients.
Reporting on utilization, eligibility, and length of stay will help providers know and understand what their patterns are, and what utilization is like in their communities.
There’s been a shift in the ownership structure of hospice. Historically, hospice operated as predominately not-for-profit. However, more than two-thirds of hospices nationwide are now operating as for-profit entities. Private equity firms have been particularly attracted to this market because it can be lucrative:
Overall, PE differentiates itself from other for-profit operating structures by have a shorter-term investment focus. One of their main goals is to help struggling businesses improve their profits.

Major forces — such as demographic pressures, Covid-19, changing Medicare enrollment, and patient preferences — have catalyzed how industry is approaching end-of-life care. These changes, along with resulting trends, will influence the future of this landscape. We see two versions of what the future could look like.
1. A continuation of the status quo due to inability to adapt reimbursement and quality standards
The combination of home-based care, the hospice carve-in under MA, and the interest of PE in hospice have the potential to reshape end-of-life care. However, transformation is less likely to happen if stakeholders fail to adapt to how we pay for end-of-life care services. True transformation is also unlikely if the health care industry fails to make large-scale updates to hospice eligibility criteria, or to what counts as curative treatments.
2. Changing ownership and investments will slowly reshape the market
Although the path forward is more likely be transformative, it might take a while for the health care industry to see the full effects. We are just now starting to see the impacts of M&A in the home care and senior care ecosystems. Also, it will take time to see the lasting impacts from the competition for resources, particularly over the limited labor supply. Finally, it has been — and will continue to be — a long journey on the road to the broader adoption of value-based care, which is influencing the interest in better end-of-life care.
Create your free account to access 1 resource, including the latest research and webinars.
You have 1 free members-only resource remaining this month.
1 free members-only resources remaining
1 free members-only resources remaining
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
You've reached your limit of free insights
Never miss out on the latest innovative health care content tailored to you.
This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece
Email ask@advisory.com to learn more
Never miss out on the latest innovative health care content tailored to you.
This is for members only. Learn more.
Never miss out on the latest innovative health care content tailored to you.